| Akron General's Vision Center | |
|
676 S Broadway St, Ste. 202, Akron, OH 44311-1059 | |
| (330) 344-2020 | |
| (330) 344-4111 |
| Full Name | Akron General's Vision Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 676 S Broadway St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114959137 | NPI | - | NPPES |
| 1750361416 | Other | OH | DR FLOWER INDIVIDUAL NPI NUMBER |
| FL0424205 | Other | OH | DR FLOWER MEDICARE INDIVIDUAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Akron General's Vision Center Po Box 715147, Columbus, OH 43271-5147 Ph: (330) 344-3583 | Akron General's Vision Center 676 S Broadway St, Ste. 202, Akron, OH 44311-1059 Ph: (330) 344-2020 |
News Archive
Smokers in the UK are much more likely to buy cheap cigarettes at a discount outlet than smokers in Australia, Canada and the USA
A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.
Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.
By integrating AtStaff's ClairVia® Patient Acuity system with its electronic medical record (EMR), Blessing Hospital of Quincy, Ill., is driving patient acuity and staffing workload directly and automatically from its existing clinical documentation - a significant advancement in evidenced-based, outcomes-driven care.
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Advanced Radiation Oncology Services in Nyack, New York.
› Verified 2 days ago
Dr. Brad Phillip Kaster, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1600 E Turkeyfoot Lake Rd Ste A, Akron, OH 44312 Phone: 330-899-7161 Fax: 330-899-7151 | |
Dr. Harry Robert Gilbert, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 767 E Turkeyfoot Lake Rd, Suite 4-a, Akron, OH 44319 Phone: 330-896-1098 | |
Handel Vision Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 919 E Turkeyfoot Lake Rd, Suite C, Akron, OH 44312 Phone: 330-899-0202 Fax: 330-899-0205 | |
Dr. Melissa Ford, OD Optometrist Medicare: Medicare Enrolled Practice Location: 687 W Market St, Akron, OH 44303 Phone: 330-253-7977 | |
Valdecir Padovan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3265 W. Market St, Akron, OH 44333 Phone: 330-697-4748 Fax: 866-425-2239 | |
Mark Denman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1948 Buchholzer Blvd., Akron, OH 44310 Phone: 330-630-5070 Fax: 330-630-5070 | |
Kenneth A Giusto, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3510 Manchester Rd, Akron, OH 44319 Phone: 330-630-9699 Fax: 330-644-0187 |